The character and space count of the running title: 45 21 The word count of the abstract: 150 22 The word count of the main text: 2057 23 24 Manuscript p. 2 Footnote 25 26 Conflict of Interest: We have no potential conflicts of interest in relation to this research. 27 28 ABSTRACT 50 Niemann-Pick C1 (NPC1), a host receptor involved in the envelope glycoprotein 51 (GP)-mediated entry of filoviruses into cells, is believed to be a major determinant of cell 52 susceptibility to filovirus infection. It is known that proteolytically digested Ebola virus 53 (EBOV) GP interacts with two protruding loops in domain C of NPC1. Using previously 54 published structural data and the single nucleotide polymorphisms (SNPs) database, we 55 identified ten naturally occurring, missense SNPs in human NPC1. To investigate whether 56 these SNPs affect cell susceptibility to filovirus infection, we generated Vero E6 cell lines 57 stably expressing NPC1 with SNP substitutions and compared their susceptibility to 58 vesicular stomatitis virus pseudotyped with filovirus GPs and infectious EBOV. We found 59 that some of the substitutions resulted in reduced susceptibility to filoviruses as indicated 60 by the lower titers and smaller plaque/focus sizes of the viruses. Our data suggest that 61 human NPC1 SNPs may likely affect host susceptibility to filoviruses.
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DISCUSSION 225 With human immunodeficiency virus type 1 (HIV-1) infection, there is a subset 226 of people who are inherently resistant to the virus [28] [29] [30] [31] . In particular, genetic variation 227 in the host viral receptors has been shown to reduce the susceptibility to HIV infection in 228 humans [28, 29] . Though asymptomatic filovirus infection is less studied, Baron et al. 229 [32] reported potential asymptomatic cases during the outbreak in Sudan in 1979, and resistance have been studied in mice [34, 35] , the details of genetic polymorphisms that 233 may affect susceptibility of humans to filoviruses have not been elucidated yet. 234 In the present study, we focused on ten reported NPC1 SNP substitutions that 235 interface with GP. Although none of the SNPs tested here completely ablated viral entry 236 or infectivity, some SNPs were nevertheless found to be important for filovirus infection. 237 In our experiments, P424A substitution reduced entry of VSV pseudotyped with 238 ebolavirus but not marburgvirus GPs. Moreover, focus sizes of EBOV-GFP were also 239 reduced in this cell line. Interestingly, Wang et al. [15] demonstrated that the P424A NPC1 240 mutant retained binding capacity to dGP but with reduced affinity compared to wild-type 241 NPC1. Taken together, these findings suggest that the P424A substitution in NPC1 lowers 242 its binding capacity to dGP, resulting in reduced viral entry and infection.
243
S425L substitution also reduced the infection with some pseudotyped VSVs, 244 including VSV∆G-MARV and -RAVV. The serine residue at position 425 in NPC1 was 245 shown to be involved in the interaction with the amino acid residue at position 142 of the 246 EBOV GP molecule [15] . However, since amino acid residues at this position are different 247 in EBOV and MARV GPs (serine at 142 of EBOV GP and glutamine at 126 of MARV p. 12 GP, respectively), the effects of S425L substitution might be different between EBOV and 249 MARV. It has also been demonstrated that single amino acid mutations at positions 502 250 or 503 in NPC1 can reduce viral infection [13, 14] . Our experiments confirmed this 251 finding as D502E substitution reduced the entry of some of the pseudotyped viruses we 252 tested and also reduced infection with EBOV-GFP (although not significantly). Notably, 253 while the previous study introduced a significant loss of charge at residue 502 by mutating 254 the aspartic acid to phenylalanine [13], our study shows that even minimal variation at 255 this residue (D to E) can have an effect on viral entry.
256
Some other amino acids that are also important for binding to dGP have not been 257 reported as SNP sites in the NPC1 loops [15] . The rapidly increasing sequence data in 258 public databases may hereafter provide additional information on NPC1 SNP 259 substitutions not evaluated in this study. It is also of interest to investigate multiple SNP 260 substutuins in the loops. Although more sensitive studies are needed to further assess the 261 capacity for NPC1 variation to influence filovirus infection, identifying genetic variations 262 that affect the susceptibility of hosts to filoviruses will be crucial in understanding 263 filovirus disease progression and host cell-restriction.
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Consisting of data provided by the authors to benefit the reader, the posted materials are 269 not copyedited and are the sole responsibility of the authors, so questions or comments 270 should be addressed to the corresponding author. Figure 1A and B ), and confirmed that its susceptibility to VSV∆G-EBOV, rVSV-EBOV, and EBOV-GFP was completely abolished (Supplementary Figure   1C Figure 2) . We also confirmed that these NPC1s were p. 9 In particular, P424A/D508N and S425L/D502E substitutions seemed to be important for the reduced entry of VSVs pseudotyped with ebolavirus and marburgvirus GPs, respectively. In some cell lines, infectivity of the viruses was enhanced and it was correlated with relatively high expression levels of NPC1 ( Supplementary Figure 2) .
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Reduced plaque-forming ability of rVSV-EBOV in Vero E6 cells expressing NPC1 with P424A or D508N substitution
We then compared the plaque-forming abilities of rVSV-EBOV and rVSV-MARV using the same cell lines (Figure 3 with the D508N substitution were significantly smaller than in 293T-NPC1expressing cells and the P424A substitution also slightly reduced the plaque size ( Figure   3B ). Consistent with the data shown in Figure 2 , rVSV-MARV formed slightly, but not significantly, smaller plaques in the cell line expressing S425L NPC1 ( Figure 3B ).
Reduced focus-forming ability of EBOV in Vero E6 cells with the P424A substitution
To examine the effects of substitutions associated with NPC1 SNPs on actual filovirus infection, we used an infectious EBOV expressing GFP and determined the viral focus numbers and average focus size in each cell line. Consistent with our pseudotyped VSV data, the P424A substitution resulted in reduced focus numbers of EBOV-GFP ( Figure 3C ). The average size of foci in this cell line was also significantly smaller than in cells expressing 293T-NPC1 ( Figure 3D ). Although these differences were not significant in a multiple comparison analysis, Welch's t-test gave significant differences compared to 293T-NPC1-expressing cells. The D508N substitution slightly reduced the focus size of EBOV-GFP but there was no statistically significant difference compared to 293T-NPC1-expressing cells. In the present study, we focused on ten reported NPC1 SNP substitutions that interface with GP. Although none of the SNPs tested here completely ablated viral entry or infectivity, some SNPs were nevertheless found to be important for filovirus infection.
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In our experiments, P424A substitution reduced entry of VSV pseudotyped with ebolavirus but not marburgvirus GPs. Moreover, focus sizes of EBOV-GFP were also reduced in this cell line. Interestingly, Wang et al. [15] demonstrated that the P424A NPC1 mutant retained binding capacity to dGP but with reduced affinity compared to wild-type NPC1. Taken together, these findings suggest that the P424A substitution in NPC1 lowers its binding capacity to dGP, resulting in reduced viral entry and infection. 
Supplementary Materials and Methods
Establishment of Vero E6/NPC1-KO
We found a candidate gRNA target sequence in the genomic region of Vero E6 clones. Cells from each well were harvested, followed by western blotting to confirm that there was no expression of NPC1. Of the 97 clones examined, we selected 2 (Vero E6/NPC1-KO cl. 19 and cl. 89) and used cl. 19 for the following experiments.
Generation of each NPC1-expressing cell line
To generate the retrovirus, Plat-GP cells were cotransfected with pMXs-puro [2] encoding HEK293T NPC1 or cDNA of each NPC1 mutant and the expression plasmid pCAGGS 
SDS-PAGE and western blotting
Cells (2 × 10 6 cells for each cell line) were lysed with 100 μl of NTE-CHAPS We found a candidate gRNA target sequence in the genomic region of Vero E6 NPC1 and designed oligonucleotides (CRISPR-VeroNPC1-F1: 5'-TAATACGACTCACTATAGCTGCTACTGTGTCCGGCGC-3' and CRISPR-VeroNPC1-R1: 5'-TTCTAGCTCTAAAACGCGCCGGACACAGTAGCAG-3') by using the CRISPRdirect web tool [1] (https://crispr.dbcls.jp/). Synthesis of a gRNA template, in vitro transcription of gRNA, and purification of gRNA products were performed using the GeneArt precision gRNA synthesis kit (Invitrogen) according to the manufacturer's instructions. Vero E6 cells were transfected with gRNA products and the Platinum Cas9 nuclease (Invitrogen) mixture using Lipofectamine CRISPRMAX Cas9 Transfection Reagent (Invitrogen) according to the manufacturer's instructions, followed by incubation for 3 days at 37°C. By genomic cleavage detection assay with a specific primer set (VeroNPC1-367F: 5'-CTGAGGAGAAGGGCAAAG-3' and VeroNPC1-846R: 5'-CATCGCTAGACCAACTTCC-3') using a GeneArt Genomic Cleavage Detection Kit (Invitrogen), we confirmed a cleaved DNA product of 426 base pairs induced by the gRNA introduction into cells. We retreated the transfected Vero E6 cells with Cas9 nuclease solution and the gRNA to generate double knockout cells. For clonal isolation, the transfected cell suspension (5 cells/ml) was seeded on 96-well plates precoated with poly D-lysine (Nunc). After clonal expansion for 3 weeks, we obtained 97 clones. Cells from each well were harvested, followed by western blotting to confirm that there was no expression of NPC1. Of the 97 clones examined, we selected 2 (Vero E6/NPC1-KO cl. 19 and cl. 89) and used cl. 19 for the following experiments.
Generation of each NPC1-expressing cell line
To generate the retrovirus, Plat-GP cells were cotransfected with pMXs-puro [2] encoding HEK293T NPC1 or cDNA of each NPC1 mutant and the expression plasmid pCAGGS [3] encoding VSV-G cDNA with FuGENE HD transfection reagent (Promega)
according to the manufacturer's recommendations. Two days later, culture supernatants containing retroviruses were collected, clarified through 0.45-μm filters, and inoculated into Vero E6/NPC1-KO cl. 19 cells. Cell lines stably expressing each NPC1 SNP were selected with DMEM containing 10% FCS and 20 μg/ml puromycin (Sigma-Aldrich).
SDS-PAGE and western blotting
Cells (2 × 10 6 cells for each cell line) were lysed with 100 μl of NTE-CHAPS 
